Updates
-
The Canadian Registry for Pulmonary Fibrosis (CARE-PF) enrolled in its first 18 months more than 1,200 people with interstitial lung disease (ILD), with more ... Read more
-
Why Common Illnesses Pose Greater Risks for Those with PF
I am slowly emerging following several weeks of hospital visits and confinement to bed. I’ve been extremely weak and unable to eat thanks to ... Read more -
Algernon’s NP-120 Surpasses Merck’s MK-7264 in Reducing Cough Frequency in Animal Model of Acute Cough, Study Shows
Algernon Pharmaceuticals‘s NP-120 (ifenprodil) outperformed Merck‘s MK-7264 (gefapixant) in an animal model of acute cough, a preclinical study by a contract research organization (CRO) shows. NP-120 is ... Read more -
Enrollment in Phase 2 Trial of Setanaxib for IPF to Start Soon
Enrollment in the Phase 2 clinical trial of setanaxib (GKT831), an oral investigational treatment for idiopathic pulmonary fibrosis (IPF), will start in the ... Read more
-
I’m Grateful to Celebrate My Fourth ‘Lungiversary’
Thanksgiving is over, but my feeling of gratitude remains. As a single-lung transplant recipient, ... -
HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or ... -
BioMed X, Boehringer Ingelheim Find Potential Therapeutic Targets for IPF
A joint research project between BioMed X and Boehringer Ingelheim has identified a new set ... -
Esbriet Reduces Risk of Acute Flares Following Cancer Removal Surgery in IPF Patients, Study Finds
Treatment with Esbriet (pirfenidone) before and after cancer removal surgery reduces the risks of ... -
Preparing for the Holiday Season as a PF Patient
I love Christmas and all that comes with it: the lights, music, decorations, parades, ... -
Idebenone, an Approved Brain Stimulant, Could Prevent and Treat PF, Study Suggests
Idebenone, an antioxidant molecule used to treat Alzheimer’s disease and other brain-damaging conditions, prevented ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests
News
Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more